secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOXYTRAN, INC (BIXT)
CIK:        0001445815
Form:       8-K
Filed at:   2026-03-20T23:59:59+00:00
Accession:  0001493152-26-011755
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioxytran completes $1.2M private placement, issues 21.1M shares and 19.8M warrants
--------------------------------------------------------------------------------

- Gross proceeds of approximately $1.2 million from sale of 21,071,667 shares at $0.055 per share.
- Warrants issued to purchase up to 19,750,001 shares at $0.12 per share, exercisable immediately for five years.
- Net proceeds to fund working capital, development programs, and commercialization of A-SUQAR dietary supplement.
- Transaction closed March 18, 2026; securities sold to accredited investors under Regulation D exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1445815/000149315226011755/0001493152-26-011755-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1445815/000149315226011755/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-011755

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer